DandRX – Coal Tar vs DandRX: A Physician's Review

Coal tar shampoos have been used for scalp conditions for well over a century — and some patients still reach for them, either out of habit, cost consideration, or because they've been told they are the strongest option available. As a physician, my assessment is more precise than that: coal tar is clinically effective, but it carries a safety and tolerability profile that makes it a difficult choice to justify for most patients managing routine seborrheic dermatitis in 2025, when better-tolerated alternatives with equivalent antifungal efficacy exist.

This review compares coal tar shampoos directly against DandRX 2% Pyrithione Zinc — not as a marketing exercise, but as a clinical comparison of mechanisms, evidence, side effects, and appropriate patient selection. There are scenarios where coal tar remains a reasonable choice. There are more scenarios where it is not the right first-line option. Understanding the distinction is the goal here.

"Coal tar works. That is not in question. The question is whether its side effect profile — photosensitivity, carcinogenicity concerns, cosmetic problems, and scalp irritation — is a reasonable trade-off when a compound with equivalent antifungal efficacy and a substantially cleaner safety record is available for the same indication."

— Dr. Deepak Khanna DO

Head-to-Head
Scorecard

A structured comparison across the dimensions that matter most to patients managing seborrheic dermatitis long-term.

Category Coal Tar DandRX 2% PZ
Antifungal Efficacy Against Malassezia overgrowth
Moderate
Strong
Anti-Inflammatory Effect Direct keratinocyte regulation
Strong
Moderate
Safety Profile Long-term use considerations
Concerns
Favorable
Daily Usability Odor, color, cosmetic tolerability
Poor
Excellent
Hair & Scalp Safety Staining, dryness, irritation risk
Stains; drying
Fragrance-free; barrier-repair paired
Photosensitivity Risk Sun exposure after use
Clinically significant
None
Pregnancy / Pediatric Use Safety in sensitive populations
Not recommended
Generally appropriate
Regulatory Status Classification and restrictions
Restricted or banned in EU/UK
FDA-recognized; globally available
Frequency Flexibility Suitability for frequent washing
2–3x/week maximum advised
Designed for consistent frequent use

What Coal Tar
Actually Is

Coal tar is a byproduct of coal carbonization — a complex mixture of over 10,000 chemical compounds including polycyclic aromatic hydrocarbons (PAHs), phenols, cresols, and heterocyclic compounds. It has been used medicinally since the late 1800s, initially for psoriasis and later for seborrheic dermatitis and other scaling scalp conditions.

Mechanism — Anti-Proliferative Coal tar directly suppresses abnormal keratinocyte proliferation — the accelerated skin cell turnover that produces scaling. It normalizes the rate of skin cell production at the scalp surface, reducing visible flaking through this anti-proliferative pathway.
Mechanism — Anti-Inflammatory Coal tar inhibits pro-inflammatory cytokine release and has direct anti-pruritic (anti-itch) properties. This makes it particularly effective for the itch and redness components of seborrheic dermatitis, independent of its antifungal activity.
Mechanism — Antifungal Coal tar has some antifungal activity, though this is not its primary or most potent mechanism. Its action against Malassezia specifically is secondary to its anti-proliferative and anti-inflammatory effects — it treats the consequences of yeast activity more than the yeast population itself.
Concentration Range OTC coal tar shampoos range from 0.5% to 5% concentration. Higher concentrations are available by prescription. The relationship between concentration and efficacy is meaningful, but higher concentrations also carry proportionally greater side effect risk — particularly photosensitivity and irritation.
Historical Context Coal tar was the dominant dermatological treatment for psoriasis and SD for much of the 20th century — largely because alternatives did not exist. Its continued use today is partly inertia and partly that it genuinely works for severe presentations where the benefit-risk trade-off is different from routine dandruff management.
Regulatory Trend The European Union and United Kingdom have restricted or effectively banned coal tar in cosmetic products over carcinogenicity concerns. The FDA in the US still recognizes it as an OTC dandruff treatment ingredient. The global regulatory divergence reflects ongoing reassessment of its long-term safety profile.

The Clinical Concerns
with Coal Tar

The concerns about coal tar for routine seborrheic dermatitis management are not theoretical. They are practical, documented, and affect the daily life of patients who use it regularly.

01
Safety Concern

Carcinogenicity: Polycyclic Aromatic Hydrocarbons

Coal tar contains polycyclic aromatic hydrocarbons (PAHs) — a class of compounds classified as probable human carcinogens by the International Agency for Research on Cancer (IARC). Occupational exposure to coal tar at high levels is associated with increased risk of skin, lung, bladder, and kidney cancers. The risk from topical OTC shampoo use at low concentrations is substantially lower than occupational exposure, but it is not zero — and critically, it is not well-characterized by long-term prospective studies in cosmetic users.

The EU's Cosmetics Regulation restricts coal tar in cosmetic products precisely because of this carcinogenicity profile. Patients who use coal tar shampoos for years or decades — as one would for a chronic condition like seborrheic dermatitis — accumulate a lifetime exposure that regulators in multiple jurisdictions consider worthy of restriction. For a condition as manageable with safer alternatives as routine SD, this is a difficult trade-off to justify clinically.

02
Practical Concern

Photosensitivity: Sun Exposure Becomes a Risk

Coal tar is a photosensitizer — it increases the skin's sensitivity to ultraviolet radiation. After using a coal tar shampoo, the scalp (and any skin that came into contact with runoff during rinsing) has significantly increased UV sensitivity for several hours to days. For patients who spend time outdoors, exercise outside, or live in sunny climates, this creates a clinically meaningful risk of accelerated photoaging and sunburn on the scalp, face, and neck.

The photosensitivity effect is particularly problematic because it directly conflicts with the lifestyle of patients most likely to be using a scalp treatment regularly — active individuals who exercise outdoors. Coal tar's photosensitization is not a trivial or rare side effect; it is a consistent pharmacological property of the compound that requires behavioral adjustment with every use.

03
Tolerability Concern

Odor and Cosmetic Acceptability

Coal tar has a strong, distinctive industrial odor that many patients find difficult to tolerate — particularly at higher concentrations. Even after thorough rinsing, the smell can persist on the hair and scalp for hours. This is not a minor cosmetic inconvenience; it is a primary driver of treatment non-adherence. A treatment that works clinically but that patients stop using because of tolerability is clinically ineffective by outcome.

For patients managing a chronic condition requiring twice to three times weekly treatment indefinitely, adherence over months and years depends heavily on how tolerable the product is to live with. Coal tar consistently underperforms on this dimension relative to Pyrithione Zinc formulations.

04
Tolerability Concern

Hair Staining — Particularly on Light Hair

Coal tar can stain light-colored, gray, or chemically treated hair a brownish or yellowish tint. This is a direct consequence of its chemical composition and is not eliminated by careful rinsing. For patients with blond, gray, silver, or highlighted hair, coal tar shampoos are often simply not a viable option — the staining effect is cosmetically unacceptable and irreversible between washes. This is an absolute contraindication for a meaningful subset of the patient population who would otherwise be appropriate candidates.

05
Population Concern

Pregnancy, Breastfeeding, and Pediatric Use

Coal tar is not recommended during pregnancy or breastfeeding due to insufficient safety data and theoretical PAH-related fetal risk. It is also used cautiously in children, with some formulations explicitly contraindicated in pediatric populations. Seborrheic dermatitis is a condition that affects people across life stages — including pregnant women, new mothers, and infants (cradle cap). Coal tar's exclusion from these populations requires treatment switching at life transitions, adding management complexity and the risk of gap periods in control.

DandRX 2% Pyrithione Zinc does not carry these population-based restrictions, making it a clinically consistent choice across these scenarios. Pregnant patients should always consult their physician before beginning any new treatment.

06
Mechanism Concern

Weaker Direct Antifungal Activity

Coal tar's primary mechanisms are anti-proliferative and anti-inflammatory — it addresses the downstream consequences of Malassezia overgrowth more effectively than it suppresses the yeast population itself. For seborrheic dermatitis, where the causative organism is the yeast, a treatment that does not directly and potently suppress Malassezia will require more frequent reapplication to maintain symptom control, and will be more vulnerable to rapid recurrence when use is interrupted. Pyrithione Zinc's zinc ion-mediated disruption of Malassezia membrane function provides more direct and sustained antifungal suppression — the mechanism is better matched to the biology of the condition.

How DandRX Works:
The Mechanism

Understanding why 2% Pyrithione Zinc is the right mechanism for seborrheic dermatitis — and why DandRX's formulation matters beyond the active ingredient — clarifies why it outperforms coal tar for most patients managing this condition.

Zinc Ion Mechanism Pyrithione Zinc releases zinc ions that disrupt Malassezia's membrane transport systems, interfering with its ability to regulate intracellular ion concentration. This disrupts cellular function and reproduction — directly targeting the causative yeast at a cellular level.
Sustained Antifungal Action Pyrithione Zinc binds to scalp keratin and delivers sustained antifungal activity between washes. This residual effect means that even on days when the shampoo is not applied, Malassezia suppression continues — reducing the rate of recolonization and extending the period of symptom control.
Anti-Inflammatory Support By reducing Malassezia population and the pro-inflammatory fatty acids it releases, Pyrithione Zinc indirectly reduces scalp inflammation — addressing itch, redness, and barrier disruption through the antifungal pathway rather than through direct keratinocyte suppression.
Fragrance-Free Formulation DandRX is formulated without synthetic fragrance — one of the most common contact sensitizers in scalp products, and a significant irritant on a scalp barrier already compromised by active SD. Fragrance elimination is not an aesthetic decision; it is a barrier-protection decision.
Sulfate-Free Base Sulfate surfactants (SLS, SLES) strip scalp barrier lipids aggressively, disrupting the acid mantle and elevating scalp pH toward yeast-favorable alkalinity. DandRX's sulfate-free base cleanse effectively without this barrier-disruption trade-off — allowing the antifungal to work without the base formula undermining it.
Paired Barrier-Repair Conditioner The DandRX conditioner is formulated specifically to restore the scalp's lipid barrier after antifungal cleansing — addressing the barrier depletion that repeated washing creates. This pairing allows patients to maintain the washing frequency required for active SD without accumulating barrier damage over time.
The Critical Distinction

Coal tar treats seborrheic dermatitis by managing the downstream consequences of Malassezia activity — slowing skin cell turnover and dampening inflammation. DandRX treats it by suppressing the causative organism directly. For a condition defined by yeast overgrowth, targeting the yeast is the more mechanistically appropriate approach — and the one with the cleaner long-term safety profile.

Full Comparison:
Coal Tar vs DandRX

Coal Tar Shampoo (0.5–5%)
Coal
Tar
MechanismAnti-proliferative, anti-inflammatory; indirect antifungal
EfficacyEffective for flaking and itch; weaker direct Malassezia suppression
SafetyPAH carcinogenicity concerns; photosensitization; restricted in EU/UK
OdorStrong, persistent industrial odor; adherence-limiting
StainingCan stain light, gray, or chemically treated hair
Sun useAvoid sun exposure for several hours after use; photosensitizer
PregnancyNot recommended; insufficient safety data
Best forSevere, treatment-resistant presentations; psoriasis-overlap cases
DandRX 2% Pyrithione Zinc
DandRX
2% PZ
MechanismDirect antifungal: zinc ion disruption of Malassezia membrane transport
EfficacyClinically equivalent or superior for SD; strong sustained Malassezia suppression
SafetyNo carcinogenicity concerns; no photosensitization; FDA-recognized; globally used
OdorFragrance-free; no lingering odor; adherence-friendly
StainingNo staining; appropriate for all hair colors and textures
Sun useNo photosensitivity; safe for outdoor use immediately after washing
PregnancyGenerally appropriate; consult physician as with any treatment
Best forRoutine to moderate SD; active patients; long-term maintenance; all hair types

Who Should Use
Which Treatment

Clinical honesty requires acknowledging that coal tar has legitimate use cases — they are simply narrower than its historical use suggests. Here is the precise patient-profile breakdown.

01
DandRX

Patients with routine to moderate seborrheic dermatitis

The vast majority of SD patients fall here — persistent dandruff, scalp itch, greasy flaking, occasional redness. For this presentation, 2% Pyrithione Zinc applied 2–3 times per week provides clinically demonstrated control without any of coal tar's tolerability or safety trade-offs. There is no clinical justification for choosing coal tar over Pyrithione Zinc for routine SD management in 2025.

02
DandRX

Active patients, outdoor workers, athletes

Anyone who spends meaningful time in the sun after washing — which is most people — should not be using a photosensitizing shampoo regularly. Coal tar's photosensitivity risk is an absolute practical barrier for this group. DandRX carries none of this risk and is formulated to support the washing frequency that active patients require.

03
DandRX

Patients with light, gray, or chemically treated hair

Coal tar staining is a disqualifying factor for this group. Pyrithione Zinc carries no staining risk and is appropriate for all hair colors, including platinum, silver, gray, bleached, or highlighted hair. There is no treatment compromise required.

04
DandRX

Pregnant patients or those planning pregnancy

Coal tar is contraindicated in pregnancy. Seborrheic dermatitis is hormonally influenced and commonly worsens during pregnancy due to elevated sebum production. DandRX provides antifungal management appropriate for this life stage — always with physician consultation, but without the categorical contraindication that coal tar carries.

05
DandRX

Long-term maintenance patients

Seborrheic dermatitis is a chronic condition — management is measured in years, not weeks. The lifetime PAH exposure accumulation from years of coal tar use is a reasonable concern that most patients have not been counseled on. For a condition where the therapeutic goal is sustained Malassezia suppression with a compound used indefinitely, DandRX's safety profile is demonstrably more appropriate for long-term use.

06
Coal Tar — Physician-Supervised

Severe, treatment-resistant seborrheic dermatitis or psoriasis overlap

Coal tar's strongest anti-proliferative and anti-inflammatory properties make it clinically relevant for severe presentations that have not responded to first- and second-line antifungal treatment, and for patients with significant psoriasis-seborrheic dermatitis overlap (sebopsoriasis), where keratinocyte proliferation control is particularly important. In these cases, under physician supervision and with appropriate sun-avoidance counseling, coal tar remains a tool in the dermatological toolkit. It is not, however, a starting point or a routine maintenance choice.

Common Questions

If coal tar is controlling your dandruff and you've tolerated it well, it is working for you in the most basic clinical sense. The question is whether you have weighed the cumulative long-term considerations — in particular, years of scalp photosensitization if you spend any meaningful time outdoors, and the PAH carcinogenicity concern that has led to regulatory restriction in Europe. Many patients who switch to DandRX find equivalent or better control without those trade-offs. The transition is straightforward: DandRX applied 2–3 times weekly using the same contact-time technique you already use. If you have severe SD that responded well to coal tar specifically after other treatments failed, discuss with your dermatologist whether there's a clinical reason to stay with it. For most patients in this scenario, the answer turns out to be no.
The honest clinical answer is: the risk from OTC shampoo use is meaningfully lower than the occupational exposures that generated the original carcinogenicity data, but it has not been adequately characterized by long-term prospective studies in cosmetic users. What we know is that coal tar contains PAHs classified as probable human carcinogens, that dermal absorption of these compounds during shampoo use does occur, and that European regulators considered the risk profile sufficient to restrict coal tar in cosmetic products. The FDA, using a different risk-benefit framework, still permits it as an OTC active ingredient. For a patient making a choice between two treatments with comparable efficacy for routine SD — one of which has this unresolved carcinogenicity question and one of which does not — the appropriate clinical recommendation is toward the one that does not.
Ketoconazole is a prescription-grade antifungal (available OTC at 1% in some markets, 2% by prescription) that directly inhibits ergosterol synthesis in Malassezia — a highly potent antifungal mechanism. In head-to-head trials, 2% ketoconazole and 2% Pyrithione Zinc show comparable efficacy for seborrheic dermatitis, with some studies showing slight ketoconazole superiority for severe presentations and others showing equivalence. For moderate SD, DandRX 2% Pyrithione Zinc is a clinically equivalent first-line option without prescription requirements, at a lower cost, and with a formulation designed for the consistent frequent use that maintenance demands. Ketoconazole is the appropriate escalation for patients whose SD is not controlled by Pyrithione Zinc after a consistent 4–6 week trial.
Alternating or combining different antifungal mechanisms is a recognized clinical strategy for difficult-to-control SD. If a dermatologist has recommended coal tar for severe or treatment-resistant symptoms, using DandRX on the alternating wash days is reasonable — it maintains antifungal Malassezia suppression on the days between coal tar applications and reduces the overall frequency of coal tar exposure. In practice, most patients who try this approach find that DandRX-only maintenance becomes sufficient once the acute flare is controlled, and coal tar use can be discontinued. This should be assessed with physician input for patients with genuinely severe or complex presentations.
Because "it works" is not sufficient justification when an alternative with equivalent or better efficacy for the target indication has a meaningfully superior safety and tolerability profile. DandRX is built around 2% Pyrithione Zinc because it is the right mechanism for seborrheic dermatitis — direct antifungal suppression of Malassezia, with residual keratinized binding for sustained effect, in a sulfate-free and fragrance-free base that protects rather than further disrupts the scalp barrier. Coal tar's anti-proliferative properties add a mechanism that is more relevant to psoriasis than to seborrheic dermatitis specifically. Adding it would mean accepting its photosensitization, odor, staining, and carcinogenicity trade-offs without meaningful additional benefit for the condition DandRX is formulated to treat.
The Right
Mechanism.

2% Pyrithione Zinc. Sulfate-free. Fragrance-free. No photosensitization, no staining, no carcinogenicity concerns. Paired with a barrier-repair conditioner for patients who need to wash frequently. Backed by a 30-day guarantee.

Medical Disclaimer: This content is for general educational purposes only and does not constitute medical advice. If you are experiencing persistent, severe, or treatment-resistant seborrheic dermatitis, please consult a licensed physician or board-certified dermatologist for diagnosis and personalized treatment recommendations. The comparison above reflects general clinical evidence and should not replace individualized medical advice. Visit dandrx.com for more information about DandRX products.

Medically Reviewed By

Dr. Khanna is a distinguished family medicine physician who brings a wealth of expertise by offering insightful and practical advice on a wide range of health concerns related to hair loss and dandruff. His experience in primary care gives him in-depth knowledge on managing common dermatological issues, including dandruff. Understanding the interplay between skin health, lifestyle factors, and medical conditions allows him to provide effective treatment strategies, from recommending medicated shampoos to addressing underlying causes such as seborrheic dermatitis or fungal infections. He provides a valuable resource for both patients and healthcare professionals, reinforcing the importance of comprehensive, patient-centered care.

Dr. Deepak Khanna D.O

Family Medicine Physician